Consolidated Entity 2025 2024 Notes US$m US$m Sales and service revenue 15,035 14,259 Influenza pandemic facility reservation fees 179 172 Royalties and license revenue 216 259 Other income 128 110 Total operating revenue 3 15,558 14,800 Cost of sales (7,479) (7,129) Gross profit 8,079 7,671 Research and development expenses 7 (1,359) (1,430) Selling and marketing expenses (1,616) (1,573) General and administration expenses (1,000) (856) Total expenses (3,975) (3,859) Net gain on business disposals 2 30 — Operating profit (EBIT) 4,134 3,812 Finance costs 3 (448) (476) Finance income 38 39 Profit before income tax expense 3,724 3,375 Income tax expense 4 (588) (661) Net profit for the year 3,136 2,714 Other comprehensive income (OCI) Items that may be reclassified subsequently to profit or loss Hedging transactions realised in profit or loss 12 (12) (11) Exchange differences on translation of foreign operations, net of gain reclassified to profit or loss upon the disposal of foreign operations 12 68 (15) Items that will not be reclassified subsequently to profit or loss Changes in fair value on equity securities measured through OCI, net of tax 12 19 3 Actuarial gains/(losses) on defined benefit plans, net of tax 18 64 (59) Total other comprehensive income/(losses) 139 (82) Total comprehensive income for the year 3,275 2,632 Net profit for the year attributable to: 3,136 2,714 - Shareholders of CSL Limited 3,002 2,642 - Non-controlling interests 134 72 Total comprehensive income for the year attributable to: 3,275 2,632 - Shareholders of CSL Limited 3,141 2,560 - Non-controlling interests 134 72 Earnings per share (based on net profit attributable to CSL Limited shareholders for the year) US$ US$ Basic earnings per share 10 6.20 5.47 Diluted earnings per share 10 6.17 5.45 The consolidated statement of comprehensive income should be read in conjunction with the accompanying notes. 90 Consolidated Statement of Comprehensive Income For the Year Ended 30 June 2025 For the Year Ended 30 June 2025 90 Financial Report
RkJQdWJsaXNoZXIy MjE2NDg3